Richard Sherry, MD

Immuno-oncology expert with deep clinical and lab experience in cellular therapy for solid tumors including shared and neo-antigen TCR directed T Cells, TIL, and Car T strategies. Executive leadership experience with cell therapy start-up focused on developing IND and first-in-human clinical trials. A research physician with over two decades of experience as an investigator, mentor, and attending surgeon at the National Cancer Institute Surgery Branch located in Bethesda, MD. Author/co-author of over 100 peer reviewed manuscripts in high impact journals.